Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Chin-Hin NG, MD MRCP, FRCPATH, MCI, Xiaojuan Chen, BsN, MsN, Foong-Gwan Lee, BsN, Shi Hui Clarice Choong, MBBS, MRCP, Xiao-Shi Saw, BSc(Pharm), Lon-Wann Sai, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Hian Li Esther Hian Li Chan, MBBS, MRCP, FRCPATH, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Yen Lin Chee, MBBS, FRCPATH, PhD, Yee Mei Lee, BsN, MsN, PhD

Blood (2019) 134 (Supplement_1): 2152.

https://doi.org/10.1182/blood-2019-129858

Published: 2019

Journal Articles

Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model

Victor Chatterjee, MD, Mohamed Samour, MBBS, Dewen You, PhD, Suman Kundu, MBA, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2308.

https://doi.org/10.1182/blood.V130.Suppl_1.2308.2308

Published: 2017

Journal Articles

Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) As First-Line Treatment in Patients with Double-Hit Lymphoma: Preliminary Results in 35 Consecutive Patients from Two Institutions

Alessandra Tucci, MD, Anna Guidetti, MD, Anna Dodero, MD, Francesca Schieppati, MD, Alessandro Re, MD, Nicola Bianchetti, MD, Chiara Bottelli, MD, Angela Passi, MD, Maria Miscio, Simona Fisogni, MD, Piera Balzarini, Fabio Facchetti, MD, Paolo Corradini, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 4154.

https://doi.org/10.1182/blood.V130.Suppl_1.4154.4154

Published: 2017

Journal Articles

Analyzing Patient Characteristics Who Received (DA) EPOCH-R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience

Blood (2016) 128 (22): 4208.

https://doi.org/10.1182/blood.V128.22.4208.4208

Published: 2016

Journal Articles

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Mohsen Saleh Elalfy, Yasser Wali, MD, FRCPCH, (UK), S Tony, Ahmed Samir, Amira Adly

Blood (2013) 122 (21): 559.

https://doi.org/10.1182/blood.V122.21.559.559

Published: 2013

Journal Articles

Hemoglobinuria and Mechanical Hemolysis Associated with Red Blood Cell Transfusion in Pediatric Patients

Janet McNaughton, MD, Jonathan Hughes, MD, Jennifer C. Andrews, MD, MSc, Tracy I. George, MD, Cassandra Bergero, RN, MSN, CNS, FNP, Kimberly Pike-Grimm, RN, MN, CNS, Susan Galel, MD, Chris Gonzalez, MD, Lawrence Goodnough, MD, Magali J. Fontaine, MD, PhD

Blood (2012) 120 (21): 3429.

https://doi.org/10.1182/blood.V120.21.3429.3429

Published: 2012

Journal Articles

Efficacy of Total Dose Administration (TDI) of 1012 Mg of Ferumoxytol Over 15 Minutes for the Treatment of Iron Deficient Anemia

Michael Auerbach, MD, William Strauss, M.D., F.A.C.C., Sarah Auerbach, Stella Rineer, Huzefa Bahrain

Blood (2012) 120 (21): 3204.

https://doi.org/10.1182/blood.V120.21.3204.3204

Published: 2012

Journal Articles

Phase I Study of On 01910.Na (rigosertib), a Multikinase PI3K Inhibitor in Relapsed/Refractory B-Cell Malignancies

Mark Roschewski, MD, Mohammed Farooqui, DO, Georg Aue, MD, Clifton C. Mo, MD, Janet Valdez, PA, Susan Soto, RN, Patricia Perez-Galan, PhD, Francois Wilhelm, MD, PhD., Adrian Wiestner, MD, PhD

Blood (2012) 120 (21): 1803.

https://doi.org/10.1182/blood.V120.21.1803.1803

Published: 2012

Journal Articles

Use of Intrathecal Ziconotide for Frequent Severe and Intractable Sickle Cell Disease-Related Pain

Gladstone C McDowell, MD, Jerry Mitchell, MD, Timothy D. Moore, MD

Blood (2011) 118 (21): 1062.

https://doi.org/10.1182/blood.V118.21.1062.1062

Published: 2011

Journal Articles

The Safety and Efficacy of Total Dose Infusion of 1020 Mg of Ferumoxytol Administered in 15 Minutes

Michael Auerbach, MD, Stella Rineer, RN, Huzefa Bahrain, DO, Sarah A Auerbach, BA

Blood (2011) 118 (21): 1042.

https://doi.org/10.1182/blood.V118.21.1042.1042

Published: 2011

Journal Articles

Shear Stress-Induced Unfolding of Von Willebrand Factor Accelerates Oxidation of Key Methionine Residues In the A1A2A3 Region

Xiaoyun Fu, Ph.D., Ryan P. Gallagher, Dominic Chung, Ph.D., Junmei Chen, Ph.D., José A. López, MD

Blood (2010) 116 (21): 2112.

https://doi.org/10.1182/blood.V116.21.2112.2112

Published: 2010

Journal Articles

Hemopexin Is Protective Against Intravascular Hemolysis–Induced Vascular Damage

Elena A Sher, Keren Hemi, Shai Efrati, Joshua Weissgarten, Matityahu Shaklai, MD, Nurith Shaklai

Blood (2010) 116 (21): 3207.

https://doi.org/10.1182/blood.V116.21.3207.3207

Published: 2010

Journal Articles

Combination of Oral Deferiprone and Subcutaneous Infusion of Desferrioxamine in Chelating Overloaded Iron in Pediatric Patients with Beta-Thalassemia Disease.

Ampaiwan Chuansumrit, MD, Nongnuch Sirachainan, MD, Suthep Wanichkul, MD, Duantida Songdej, MD, Pakawan Wongwerawattanakoon, B.Sc., Praguywan Kadegasem, B.Sc.

Blood (2009) 114 (22): 4057.

https://doi.org/10.1182/blood.V114.22.4057.4057

Published: 2009

Journal Articles

Phlebotomy and Bolus Subcutaneous Deferoxamine in Algerian Patients with Thalassemia Major or Intermedia or Sickle Cell Disease Treated with Hydroxyurea.

Mohamed Bradai, MD, Dora Bachir, MD, Mariane De Montalembert, MD

Blood (2007) 110 (11): 3812.

https://doi.org/10.1182/blood.V110.11.3812.3812

Published: 2007

Journal Articles

A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by 24 Hour Infusion Every 2 Weeks to Patients with Myeloid Malignancies and Chronic Lymphocytic Leukemia (CLL).

Gautam Borthakur, Susan O’Brien, Farhad Ravandi-Kashani, Francis Giles, Aaron D. Schimmer, Jean Viallet, Hagop Kantarjian

Blood (2006) 108 (11): 2654.

https://doi.org/10.1182/blood.V108.11.2654.2654

Published: 2006

Journal Articles

Stability and Sterility of Sucrose-Formulated Recombinant Factor VIII (Kogenate® FS/Bayer) for Use during Continuous Infusion.

Lisa Regan, Jordan Chew, Khang Vo, Joyce Leveque, Naji Khabbaz, Eduard Gorina

Blood (2006) 108 (11): 4004.

https://doi.org/10.1182/blood.V108.11.4004.4004

Published: 2006

Journal Articles

Phase 2 Multicenter Trial of Gallium Nitrate in Patients with Advanced Non-Hodgkin’s Lymphoma (NHL).

Barbara Pro, MD, R. G. Bociek, MD, Christopher R. Chitambar, MD, Stephanie A. Gregory, MD, John P. Leonard, MD, Sandra Smith, Steven Novick, MD

Blood (2004) 104 (11): 2487.

https://doi.org/10.1182/blood.V104.11.2487.2487

Published: 2004

Journal Articles

Evaluation of Stability of a Sucrose-Formulated, Full-Length rFVIII for Use in Continuous Infusion Therapy.

Uri Martinowitz, Aaron Lubetsky, Ilia Tamarin, Jacob Luboshitz

Blood (2004) 104 (11): 4114.

https://doi.org/10.1182/blood.V104.11.4114.4114

Published: 2004

Journal Articles

Individualized Once-Daily Dosing of Intravenous Busulfan: A Pharmacokinetic Study in Patients Undergoing Conditioning for Allogeneic Stem Cell Transplantation.

Shabal B. Kangarloo, MSc, Farrukh Naveed, BSc, Borje S. Andersson, MD, PhD, Diana Quinlan, BN, James A. Russell, FRCP

Blood (2004) 104 (11): 98.

https://doi.org/10.1182/blood.V104.11.98.98

Published: 2004

NARROW

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model

Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) As First-Line Treatment in Patients with Double-Hit Lymphoma: Preliminary Results in 35 Consecutive Patients from Two Institutions

Analyzing Patient Characteristics Who Received (DA) EPOCH-R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Hemoglobinuria and Mechanical Hemolysis Associated with Red Blood Cell Transfusion in Pediatric Patients

Efficacy of Total Dose Administration (TDI) of 1012 Mg of Ferumoxytol Over 15 Minutes for the Treatment of Iron Deficient Anemia

Phase I Study of On 01910.Na (rigosertib), a Multikinase PI3K Inhibitor in Relapsed/Refractory B-Cell Malignancies

Use of Intrathecal Ziconotide for Frequent Severe and Intractable Sickle Cell Disease-Related Pain

The Safety and Efficacy of Total Dose Infusion of 1020 Mg of Ferumoxytol Administered in 15 Minutes

Shear Stress-Induced Unfolding of Von Willebrand Factor Accelerates Oxidation of Key Methionine Residues In the A1A2A3 Region

Hemopexin Is Protective Against Intravascular Hemolysis–Induced Vascular Damage

Combination of Oral Deferiprone and Subcutaneous Infusion of Desferrioxamine in Chelating Overloaded Iron in Pediatric Patients with Beta-Thalassemia Disease.

Phlebotomy and Bolus Subcutaneous Deferoxamine in Algerian Patients with Thalassemia Major or Intermedia or Sickle Cell Disease Treated with Hydroxyurea.

A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by 24 Hour Infusion Every 2 Weeks to Patients with Myeloid Malignancies and Chronic Lymphocytic Leukemia (CLL).

Stability and Sterility of Sucrose-Formulated Recombinant Factor VIII (Kogenate® FS/Bayer) for Use during Continuous Infusion.

Phase 2 Multicenter Trial of Gallium Nitrate in Patients with Advanced Non-Hodgkin’s Lymphoma (NHL).

Evaluation of Stability of a Sucrose-Formulated, Full-Length rFVIII for Use in Continuous Infusion Therapy.

Individualized Once-Daily Dosing of Intravenous Busulfan: A Pharmacokinetic Study in Patients Undergoing Conditioning for Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only